Regional fat distribution and blood pressure level and variability

Hypertension

Volumn 68, Issue 3, 2016, Pages 576-583

  Yano, Yuichiro ^a   Vongpatanasin, Wanpen ^b   Ayers, Colby ^c   Turer, Aslan ^b   Chandra, Alvin ^b   Carnethon, Mercedes R ^a   Greenland, Philip ^a   De Lemos, James A ^b   Neeland, Ian J ^b  

^a NORTHWESTERN UNIVERSITY   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c UNIVERSITY OF TEXAS AT DALLAS   (United States)

Author keywords

adipokine; adiponectin blood pressure hypertension intra abdominal fat obesity visceral adipose tissue

Indexed keywords

ADIPONECTIN; ALDOSTERONE; ANTIHYPERTENSIVE AGENT; LEPTIN;

ABDOMINAL SUBCUTANEOUS FAT; ADULT; AGE; ARTICLE; BLACK PERSON; BLOOD PRESSURE VARIABILITY; BODY FAT; BODY FAT DISTRIBUTION; BODY MASS; COHORT ANALYSIS; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; DUAL ENERGY X RAY ABSORPTIOMETRY; FAT MASS; FEMALE; GLOMERULUS FILTRATION RATE; HEART RATE; HUMAN; INSULIN RESISTANCE; INTRAABDOMINAL FAT; INTRAPERITONEAL FAT; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OBESITY; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PROFESSIONAL PRACTICE; PROTEIN BLOOD LEVEL; RACE DIFFERENCE; RETROPERITONEAL FAT; SEX DIFFERENCE; SUBCUTANEOUS FAT; SYSTOLIC BLOOD PRESSURE; ADVERSE EFFECTS; BLOOD PRESSURE MONITORING; CARDIOVASCULAR DISEASES; CLINICAL TRIAL; COMORBIDITY; COMPARATIVE STUDY; DISEASE COURSE; HYPERTENSION; MIDDLE AGED; MULTICENTER STUDY; MULTIVARIATE ANALYSIS; PATHOPHYSIOLOGY; PROCEDURES; PROGNOSIS; RISK ASSESSMENT; STATISTICAL MODEL; TEXAS;

ADULT; AGE FACTORS; BLOOD PRESSURE MONITORING, AMBULATORY; BODY FAT DISTRIBUTION; BODY MASS INDEX; CARDIOVASCULAR DISEASES; COHORT STUDIES; COMORBIDITY; DISEASE PROGRESSION; FEMALE; HUMANS; HYPERTENSION; INTRA-ABDOMINAL FAT; LINEAR MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; OBESITY; PROGNOSIS; RISK ASSESSMENT; SEX FACTORS; SUBCUTANEOUS FAT; TEXAS;

EID: 84978766123     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.116.07876     Document Type: Article

References (46)

1. Kannel WB, Brand N, Skinner JJ Jr, Dawber TR, McNamara PM, The relation of adiposity to blood pressure and development of hypertension The Framingham study. Ann Intern Med 1967 67 48 59
2. Stamler R, Stamler J, Riedlinger WF, Algera G, Roberts RH, Weight and blood pressure. Findings in hypertension screening of 1 million Americans. JAMA 1978 240 1607 1610
3. DeMarco VG, Aroor AR, Sowers JR, The pathophysiology of hypertension in patients with obesity. Nat Rev Endocrinol 2014 10 364 376. doi: 10.1038/nrendo.2014.44
4. Canoy D, Luben R, Welch A, Bingham S, Wareham N, Day N, Khaw KT, Fat distribution, body mass index and blood pressure in 22,090 men and women in the Norfolk cohort of the European Prospective Investigation into Cancer and Nutrition (EPIC-Norfolk) study. J Hypertens 2004 22 2067 2074
5. Hall JE, do Carmo JM, da Silva AA, Wang Z, Hall ME, Obesity-induced hypertension: interaction of neurohumoral and renal mechanisms. Circ Res 2015 116 991 1006. doi: 10.1161/CIRCRESAHA.116.305697
6. Sironi AM, Gastaldelli A, Mari A, Ciociaro D, Positano V, Postano V, Buzzigoli E, Ghione S, Turchi S, Lombardi M, Ferrannini E, Visceral fat in hypertension: influence on insulin resistance and beta-cell function. Hypertension 2004 44 127 133. doi: 10.1161/01.HYP.0000137982.10191.0a
7. Hayashi T, Boyko EJ, Leonetti DL, McNeely MJ, Newell-Morris L, Kahn SE, Fujimoto WY, Visceral adiposity is an independent predictor of incident hypertension in Japanese Americans. Ann Intern Med 2004 140 992 1000
8. Chandra A, Neeland IJ, Berry JD, Ayers CR, Rohatgi A, Das SR, Khera A, McGuire DK, de Lemos JA, Turer AT, The relationship of body mass and fat distribution with incident hypertension: observations from the Dallas Heart Study. J Am Coll Cardiol 2014 64 997 1002. doi: 10.1016/j.jacc.2014.05.057
9. Yano Y, Kario K, Nocturnal blood pressure and cardiovascular disease: a review of recent advances. Hypertens Res 2012 35 695 701. doi: 10.1038/hr.2012.26
10. Pickering TG, Shimbo D, Haas D, Ambulatory blood-pressure monitoring. N Engl J Med 2006 354 2368 2374. doi: 10.1056/NEJMra060433
11. Rothwell PM, Howard SC, Dolan E, O'Brien E, Dobson JE, Dahlöf B, Sever PS, Poulter NR, Prognostic significance of visit-To-visit variability, maximum systolic blood pressure, and episodic hypertension. Lancet 2010 375 895 905. doi: 10.1016/S0140-6736(10)60308-X
12. Hastie CE, Jeemon P, Coleman H, McCallum L, Patel R, Dawson J, Sloan W, Meredith P, Jones GC, Muir S, Walters M, Dominiczak AF, Morrison D, McInnes GT, Padmanabhan S, Long-Term and ultra long-Term blood pressure variability during follow-up and mortality in 14,522 patients with hypertension. Hypertension 2013 62 698 705. doi: 10.1161/HYPERTENSIONAHA.113.01343
13. Parati G, Ochoa JE, Lombardi C, Bilo G, Assessment and management of blood-pressure variability. Nat Rev Cardiol 2013 10 143 155. doi: 10.1038/nrcardio.2013.1
14. Yano Y, Ning H, Allen N, Reis JP, Launer LJ, Liu K, Yaffe K, Greenland P, Lloyd-Jones DM, Long-Term blood pressure variability throughout young adulthood and cognitive function in midlife: the Coronary Artery Risk Development in Young Adults (CARDIA) study. Hypertension 2014 64 983 988. doi: 10.1161/HYPERTENSIONAHA.114.03978
15. Muntner P, Shimbo D, Tonelli M, Reynolds K, Arnett DK, Oparil S, The relationship between visit-To-visit variability in systolic blood pressure and all-cause mortality in the general population: findings from NHANES III, 1988 to 1994. Hypertension 2011 57 160 166. doi: 10.1161/HYPERTENSIONAHA.110.162255
16. Yano Y, Fujimoto S, Kramer H, Long-Term blood pressure variability, new-onset diabetes mellitus, and new-onset chronic kidney disease in the Japanese general population. Hypertension 2015 66 30 36. doi: 10.1161/HYPERTENSIONAHA.115.05472
17. Muntner P, Levitan EB, Reynolds K, Mann DM, Tonelli M, Oparil S, Shimbo D, Within-visit variability of blood pressure and all-cause and cardiovascular mortality among US adults. J Clin Hypertens (Greenwich) 2012 14 165 171. doi: 10.1111/j.1751-7176.2011.00581.x
18. Li Y, Liu J, Wang W, Zhao D, The association between within-visit blood pressure variability and carotid artery atherosclerosis in general population. PLoS One 2014 9 e97760. doi: 10.1371/journal.pone.0097760
19. Schutte R, Thijs L, Liu YP, Asayama K, Jin Y, Odili A, Gu YM, Kuznetsova T, Jacobs L, Staessen JA, Within-subject blood pressure level-not variability-predicts fatal and nonfatal outcomes in a general population. Hypertension 2012 60 1138 1147. doi: 10.1161/HYPERTENSIONAHA.112.202143
20. Després JP, Body fat distribution and risk of cardiovascular disease: an update. Circulation 2012 126 1301 1313. doi: 10.1161/CIRCULATIONAHA.111.067264
21. Karpe F, Pinnick KE, Biology of upper-body and lower-body adipose tissue-link to whole-body phenotypes. Nat Rev Endocrinol 2015 11 90 100. doi: 10.1038/nrendo.2014.185
22. Hu G, Jousilahti P, Antikainen R, Katzmarzyk PT, Tuomilehto J, Joint effects of physical activity, body mass index, waist circumference, and waist-To-hip ratio on the risk of heart failure. Circulation 2010 121 237 244. doi: 10.1161/CIRCULATIONAHA.109.887893
23. Neeland IJ, Gupta S, Ayers CR, Turer AT, Rame JE, Das SR, Berry JD, Khera A, McGuire DK, Vega GL, Grundy SM, de Lemos JA, Drazner MH, Relation of regional fat distribution to left ventricular structure and function. Circ Cardiovasc Imaging 2013 6 800 807. doi: 10.1161/CIRCIMAGING.113.000532
24. Neeland IJ, Winders BR, Ayers CR, Das SR, Chang AY, Berry JD, Khera A, McGuire DK, Vega GL, de Lemos JA, Turer AT, Higher natriuretic peptide levels associate with a favorable adipose tissue distribution profile. J Am Coll Cardiol 2013 62 752 760. doi: 10.1016/j.jacc.2013.03.038
25. Wang ZV, Scherer PE, Adiponectin, cardiovascular function, and hypertension. Hypertension 2008 51 8 14. doi: 10.1161/HYPERTENSIONAHA.107.099424
26. Victor RG, Haley RW, Willett DL, Peshock RM, Vaeth PC, Leonard D, Basit M, Cooper RS, Iannacchione VG, Visscher WA, Staab JM, Hobbs HH, Dallas Heart Study Investigators The Dallas Heart Study: a population-based probability sample for the multidisciplinary study of ethnic differences in cardiovascular health. Am J Cardiol 2004 93 1473 1480. doi: 10.1016/j.amjcard.2004.02.058
27. Levitan EB, Kaciroti N, Oparil S, Julius S, Muntner P, Blood pressure measurement device, number and timing of visits, and intra-individual visit-To-visit variability of blood pressure. J Clin Hypertens (Greenwich) 2012 14 744 750. doi: 10.1111/jch.12005
28. Diaz KM, Tanner RM, Falzon L, Levitan EB, Reynolds K, Shimbo D, Muntner P, Visit-To-visit variability of blood pressure and cardiovascular disease and all-cause mortality: a systematic review and meta-Analysis. Hypertension 2014 64 965 982. doi: 10.1161/HYPERTENSIONAHA.114.03903
29. Stolarz-Skrzypek K, Thijs L, Richart T, Li Y, Hansen TW, Boggia J, Kuznetsova T, Kikuya M, Kawecka-Jaszcz K, Staessen JA, Blood pressure variability in relation to outcome in the International Database of Ambulatory blood pressure in relation to Cardiovascular Outcome. Hypertens Res 2010 33 757 766. doi: 10.1038/hr.2010.110
30. Shin JH, Shin J, Kim BK, Lim YH, Park HC, Choi SI, Kim SG, Kim JH, Within-visit blood pressure variability: relevant factors in the general population. J Hum Hypertens 2013 27 328 334. doi: 10.1038/jhh.2012.39
31. Ainsworth BE, Haskell WL, Whitt MC, Irwin ML, Swartz AM, Strath SJ, O'Brien WL, Bassett DR Jr, Schmitz KH, Emplaincourt PO, Jacobs DR Jr, Leon AS, Compendium of physical activities: an update of activity codes and MET intensities. Med Sci Sports Exerc 2000 32 suppl 9 S498 S504
32. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, Coresh J, CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration) A new equation to estimate glomerular filtration rate. Ann Intern Med 2009 150 604 612
33. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC, Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985 28 412 419
34. Abate N, Burns D, Peshock RM, Garg A, Grundy SM, Estimation of adipose tissue mass by magnetic resonance imaging: validation against dissection in human cadavers. J Lipid Res 1994 35 1490 1496
35. Abate N, Garg A, Coleman R, Grundy SM, Peshock RM, Prediction of total subcutaneous abdominal, intraperitoneal, and retroperitoneal adipose tissue masses in men by a single axial magnetic resonance imaging slice. Am J Clin Nutr 1997 65 403 408
36. Vega GL, Adams-Huet B, Peshock R, Willett D, Shah B, Grundy SM, Influence of body fat content and distribution on variation in metabolic risk. J Clin Endocrinol Metab 2006 91 4459 4466. doi: 10.1210/jc.2006-0814
37. Szczepaniak LS, Babcock EE, Schick F, Dobbins RL, Garg A, Burns DK, McGarry JD, Stein DT, Measurement of intracellular triglyceride stores by H spectroscopy: validation in vivo. Am J Physiol 1999 276 5 pt 1 E977 E989
38. Greenland S, Rothman KJ, Greenland S, Lash TL, Introduction to regression. In: Modern Epidemiology 2008 3rd edn Lippincot Williams & Wilkins 418 458
39. Beske SD, Alvarez GE, Ballard TP, Davy KP, Reduced cardiovagal baroreflex gain in visceral obesity: implications for the metabolic syndrome. Am J Physiol Heart Circ Physiol 2002 282 H630 H635. doi: 10.1152/ajpheart.00642.2001
40. Grassi G, Dell'Oro R, Facchini A, Quarti Trevano F, Bolla GB, Mancia G, Effect of central and peripheral body fat distribution on sympathetic and baroreflex function in obese normotensives. J Hypertens 2004 22 2363 2369
41. Alvarez GE, Beske SD, Ballard TP, Davy KP, Sympathetic neural activation in visceral obesity. Circulation 2002 106 2533 2536
42. Foster MC, Hwang SJ, Porter SA, Massaro JM, Hoffmann U, Fox CS, Fatty kidney, hypertension, and chronic kidney disease: the Framingham Heart Study. Hypertension 2011 58 784 790. doi: 10.1161/HYPERTENSIONAHA.111.175315
43. Grassi G, Vailati S, Bertinieri G, Seravalle G, Stella ML, Dell'Oro R, Mancia G, Heart rate as marker of sympathetic activity. J Hypertens 1998 16 1635 1639
44. Freitag MH, Larson MG, Levy D, Benjamin EJ, Wang TJ, Leip EP, Wilson PW, Vasan RS, Framingham Heart Study Plasma brain natriuretic peptide levels and blood pressure tracking in the Framingham Heart Study. Hypertension 2003 41 978 983. doi: 10.1161/01.HYP.0000061116.20490.8D
45. Stergiou GS, Asayama K, Thijs L, Kollias A, Niiranen TJ, Hozawa A, Boggia J, Johansson JK, Ohkubo T, Tsuji I, Jula AM, Imai Y, Staessen JA, International Database on HOme blood pressure in relation to Cardiovascular Outcome (IDHOCO) Investigators Prognosis of white-coat and masked hypertension: International Database of HOme blood pressure in relation to Cardiovascular Outcome. Hypertension 2014 63 675 682. doi: 10.1161/HYPERTENSIONAHA.113.02741
46. Tientcheu D, Ayers C, Das SR, McGuire DK, de Lemos JA, Khera A, Kaplan N, Victor R, Vongpatanasin W, Target organ complications and cardiovascular events associated with masked hypertension and white-coat hypertension: analysis from the Dallas Heart Study. J Am Coll Cardiol 2015 66 2159 2169. doi: 10.1016/j.jacc.2015.09.007